Literature DB >> 3768302

Kinetics of the inhibition of thrombin by hirudin.

S R Stone, J Hofsteenge.   

Abstract

The dissociation constant for hirudin was determined by varying the concentration of hirudin in the presence of a fixed concentration of thrombin and tripeptidyl p-nitroanilide substrate. The estimate of the dissociation constant determined in this manner displayed a dependence on the concentration of substrate which suggested the existence of two binding sites at which the substrate was able to compete with hirudin. A high-affinity site could be correlated with the binding of the substrate at the active site, and the other site had an affinity for the substrate that was 2 orders of magnitude lower. Extrapolation to zero substrate concentration yielded a value of 20 fM for the dissociation constant of hirudin at an ionic strength of 0.125. The dissociation constant for hirudin was markedly dependent on the ionic strength of the assay; it increased 20-fold when the ionic strength was increased from 0.1 to 0.4. This increase in dissociation constant was accompanied by a decrease in the rate with which hirudin associated with thrombin. This rate could be measured with a conventional recording spectrophotometer at higher ionic strength and was found to be independent of the binding of substrate at the active site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768302     DOI: 10.1021/bi00364a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  96 in total

1.  The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.

Authors:  S P Bottomley; I D Lawrenson; D Tew; W Dai; J C Whisstock; R N Pike
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Electrostatic interactions in the association of proteins: an analysis of the thrombin-hirudin complex.

Authors:  A Karshikov; W Bode; A Tulinsky; S R Stone
Journal:  Protein Sci       Date:  1992-06       Impact factor: 6.725

3.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

4.  The human estrogen sulfotransferase: a half-site reactive enzyme.

Authors:  Meihao Sun; Thomas S Leyh
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

5.  Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold.

Authors:  Austin D Vogt; Pradipta Chakraborty; Enrico Di Cera
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

6.  Mechanism and rate constants of the Cdc42 GTPase binding with intrinsically disordered effectors.

Authors:  Xiaodong Pang; Huan-Xiang Zhou
Journal:  Proteins       Date:  2016-03-09

7.  The role of protease-activated receptor-1 in bone healing.

Authors:  Shu Jun Song; Charles N Pagel; Therese M Campbell; Robert N Pike; Eleanor J Mackie
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation.

Authors:  V L Turgeon; E D Lloyd; S Wang; B W Festoff; L J Houenou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

9.  Ribonuclease A variants with potent cytotoxic activity.

Authors:  P A Leland; L W Schultz; B M Kim; R T Raines
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  A plasmin-activatable thrombin inhibitor reduces experimental thrombosis and assists experimental thrombolysis in murine models.

Authors:  W P Sheffield; L J Eltringham-Smith; S Gataiance; V Bhakta
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.